Matthew Winkler, Ph.D.

Dr. Winkler has served on our board of directors since July 2017. Dr. Winkler is the former Chairman and founder of Asuragen.  Asuragen was sold in 2021 to Bio-Techne. He also founded Mirna Therapeutics(MIRN) (merged with Synlogic 2017) and Ambion, Inc. Ambion was acquired in 2006 by Applied Biosystems, now Thermo Fisher Scientific. Dr. Winkler currently serves on the board of directors of “The Breakthrough Institute”, “Revive and Restore” and KLRU Television, all from 2017 to present. Dr. Winkler was an Assistant and Associate Professor (1983-1991) in the Department of Zoology at the University of Texas at Austin, where he is also currently a member of several advisory boards. Dr. Winkler received his B.S. in Genetics and a Ph.D. in Zoology from the University of California at Berkeley. The board of directors believes that Dr. Winkler is qualified to serve on our board of directors due to his extensive operational experience with global life sciences companies, and particularly his expertise in business development and corporate strategy.